4Filed Aug 26, 8:00 PM ET

Enova (ENVA) Exec Chairman David Fisher Exercises Options and Sells Shares

$ENVA · Enova International, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Enova (ENVA) Exec Chairman David Fisher Exercises Options and Sells Shares

What Happened

  • David Fisher, Executive Chairman and Director of Enova International (ENVA), exercised stock appreciation rights/options and immediately sold the resulting shares. He exercised 9,491 shares on Aug 25 and 9,078 shares on Aug 26, and sold those same shares in open‑market trades. Total shares sold: 18,569 for aggregate gross proceeds of approximately $4,487,026. The cash paid to exercise the awards was about $384,935 (combined).
  • Sales were executed under a prearranged Rule 10b5‑1 trading plan adopted Jan 30, 2026, and the filing was made on Aug 27, 2026 (timely within Form 4 rules). The derivative entries showing $0 appear because the exercise of the SAR caused related options to expire (see footnote).

Key Details

  • Transaction dates: Exercises on 2026‑08‑25 (9,491 shares) and 2026‑08‑26 (9,078 shares); sales on 2026‑08‑25 and 2026‑08‑26.
  • Sale prices (weighted averages): $244.01 (Aug 25; range $241.46–$251.20) and $239.16 (Aug 26; range $236.29–$244.93).
  • Gross proceeds from sales: ~$2,315,903 (Aug 25) and ~$2,171,123 (Aug 26); total ~$4,487,026. Exercise payments: ~$196,748 and ~$188,187 (total ~$384,935).
  • Shares owned after transaction: not disclosed in the provided filing excerpt.
  • Notable footnotes: sale effected pursuant to a 10b5‑1 plan (F1); multiple‑trade price ranges reported (F2, F3); SAR and option were granted in tandem so exercise of one cancels the other (F4); definitions of Offer/Offer Value apply to SAR payout conditions (F5). Options had vested in three equal annual installments (Feb 11, 2021–2023) (F6).
  • Filing timeliness: Form 4 filed Aug 27, 2026 for transactions on Aug 25–26 — within the standard reporting window.

Context

  • This was an exercise of derivative awards (SAR/options) followed by immediate open‑market sales — commonly a cashless exercise and disposition rather than an ordinary open‑market purchase. Such transactions are typically routine when insiders exercise and liquidate vested awards; they do not, by themselves, indicate the insider’s view of the company’s future.